Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database

Objectives To compare the risk of cardiovascular events among Janus kinase inhibitors (JAKIs), biological disease-modifying antirheumatic drugs (bDMARDs) (tumour necrosis factor inhibitors (TNFIs) and non-TNFIs) and methotrexate (MTX) in Japanese patients with rheumatoid arthritis (RA).Methods Using...

Full description

Bibliographic Details

Published in:	RMD Open
Main Authors:	Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, Ryoko Sakai
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-05-01
Online Access:	https://rmdopen.bmj.com/content/10/2/e003885.full